The Federal Patent Court in Germany has found the formulation patent protecting Seroquel XR (quetiapine fumarate) prolonged-release tablets � marketed...
A US court has ruled that the formulation patent for the extended-release version of the antipsychotic Seroquel XR is valid...
The UK High Court has ruled that AstraZeneca's patent on the extended-release version of Seroquel XR (quetiapine fumarate) is invalid....
Seroquel XL is indicated for: • treatment of schizophrenia • treatment of bipolar disorder: - For the treatment of moderate to severe manic episodes in bipolar disorder - For the treatment of major depressive episodes in bipolar disorder - For the prevention of recurrence of manic or depressed episodes in patients with bipolar disorder who previously responded to quetiapine treatment. • add-on treatment of major depressive episodes in patients with Major Depressive Disorder (MDD) who have had sub-optimal response to antidepressant monotherapy (see section 5.1). Prior to initiating treatment, clinicians should consider the safety profile of Seroquel XL (see section 4.4).
Teva Pharma UK has launched generic versions of Seroquel and Seroquel XL as Quetiapine and Quetiapine XL.Other generic versions are...